PVLA
Palvella Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$157.24
+1.14%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 177.57x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 10.45x
- Price / sales
- —
- Price / cash flow
- -62.05x
Enterprise value
- Enterprise value
- $2.0B
- EV / sales
- —
- EV / EBITDA
- -40.31x
- EV / EBIT
- -34.91x
- Market cap
- $2.3B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026